nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2D6—breast cancer	0.0865	0.389	CbGaD
Nicardipine—CYP3A4—breast cancer	0.0742	0.333	CbGaD
Nicardipine—ABCB1—breast cancer	0.0617	0.278	CbGaD
Nicardipine—CYP2B6—Thiotepa—breast cancer	0.0233	0.0549	CbGbCtD
Nicardipine—CYP2C9—Anastrozole—breast cancer	0.0162	0.0383	CbGbCtD
Nicardipine—CYP3A5—Lapatinib—breast cancer	0.0161	0.0381	CbGbCtD
Nicardipine—CYP2B6—Raloxifene—breast cancer	0.0155	0.0366	CbGbCtD
Nicardipine—CYP2C8—Lapatinib—breast cancer	0.0155	0.0366	CbGbCtD
Nicardipine—ABCB1—Toremifene—breast cancer	0.0144	0.034	CbGbCtD
Nicardipine—CYP2C19—Lapatinib—breast cancer	0.013	0.0307	CbGbCtD
Nicardipine—CYP3A4—Exemestane—breast cancer	0.0124	0.0294	CbGbCtD
Nicardipine—CYP2C9—Idarubicin—breast cancer	0.0123	0.029	CbGbCtD
Nicardipine—CYP2C8—Raloxifene—breast cancer	0.0118	0.0278	CbGbCtD
Nicardipine—CYP2D6—Idarubicin—breast cancer	0.0112	0.0265	CbGbCtD
Nicardipine—CYP3A4—Letrozole—breast cancer	0.0106	0.025	CbGbCtD
Nicardipine—ABCB1—Lapatinib—breast cancer	0.0105	0.0248	CbGbCtD
Nicardipine—CYP2E1—Tamoxifen—breast cancer	0.0104	0.0245	CbGbCtD
Nicardipine—CYP2B6—Tamoxifen—breast cancer	0.0103	0.0242	CbGbCtD
Nicardipine—CYP2E1—Mitoxantrone—breast cancer	0.0101	0.0239	CbGbCtD
Nicardipine—CYP3A4—Anastrozole—breast cancer	0.00942	0.0223	CbGbCtD
Nicardipine—CYP3A4—Toremifene—breast cancer	0.00862	0.0204	CbGbCtD
Nicardipine—CYP3A5—Tamoxifen—breast cancer	0.00807	0.0191	CbGbCtD
Nicardipine—CYP3A4—Fulvestrant—breast cancer	0.00801	0.0189	CbGbCtD
Nicardipine—CYP2B6—Irinotecan—breast cancer	0.00787	0.0186	CbGbCtD
Nicardipine—CYP2C8—Tamoxifen—breast cancer	0.00776	0.0183	CbGbCtD
Nicardipine—CYP3A4—Thiotepa—breast cancer	0.00714	0.0169	CbGbCtD
Nicardipine—CYP2C9—Capecitabine—breast cancer	0.00673	0.0159	CbGbCtD
Nicardipine—CYP3A4—Ixabepilone—breast cancer	0.00653	0.0154	CbGbCtD
Nicardipine—CYP2C19—Tamoxifen—breast cancer	0.00651	0.0154	CbGbCtD
Nicardipine—CYP3A4—Lapatinib—breast cancer	0.00629	0.0149	CbGbCtD
Nicardipine—CYP3A5—Paclitaxel—breast cancer	0.00629	0.0148	CbGbCtD
Nicardipine—CYP3A5—Irinotecan—breast cancer	0.0062	0.0146	CbGbCtD
Nicardipine—CYP2C8—Paclitaxel—breast cancer	0.00604	0.0143	CbGbCtD
Nicardipine—ABCB1—Vinorelbine—breast cancer	0.00582	0.0137	CbGbCtD
Nicardipine—CYP2C8—Fluorouracil—breast cancer	0.00572	0.0135	CbGbCtD
Nicardipine—CYP2D6—Vinorelbine—breast cancer	0.00549	0.013	CbGbCtD
Nicardipine—CYP2C9—Tamoxifen—breast cancer	0.00542	0.0128	CbGbCtD
Nicardipine—ABCB1—Tamoxifen—breast cancer	0.00526	0.0124	CbGbCtD
Nicardipine—ABCB1—Mitoxantrone—breast cancer	0.00513	0.0121	CbGbCtD
Nicardipine—CYP2D6—Tamoxifen—breast cancer	0.00495	0.0117	CbGbCtD
Nicardipine—CYP3A4—Raloxifene—breast cancer	0.00477	0.0113	CbGbCtD
Nicardipine—CYP3A5—Docetaxel—breast cancer	0.00454	0.0107	CbGbCtD
Nicardipine—ABCB1—Gemcitabine—breast cancer	0.00453	0.0107	CbGbCtD
Nicardipine—CYP2B6—Doxorubicin—breast cancer	0.0043	0.0102	CbGbCtD
Nicardipine—CYP2C9—Paclitaxel—breast cancer	0.00421	0.00995	CbGbCtD
Nicardipine—ABCB1—Paclitaxel—breast cancer	0.00409	0.00966	CbGbCtD
Nicardipine—ABCB1—Irinotecan—breast cancer	0.00404	0.00953	CbGbCtD
Nicardipine—CYP2C9—Fluorouracil—breast cancer	0.00399	0.00942	CbGbCtD
Nicardipine—ABCB1—Vinblastine—breast cancer	0.00359	0.00847	CbGbCtD
Nicardipine—CYP3A4—Vinorelbine—breast cancer	0.00349	0.00824	CbGbCtD
Nicardipine—CYP2D6—Vinblastine—breast cancer	0.00338	0.00798	CbGbCtD
Nicardipine—CHRM3—muscle of abdomen—breast cancer	0.00329	0.0678	CbGeAlD
Nicardipine—CYP3A4—Tamoxifen—breast cancer	0.00315	0.00744	CbGbCtD
Nicardipine—CYP3A4—Mitoxantrone—breast cancer	0.00307	0.00725	CbGbCtD
Nicardipine—ABCB1—Docetaxel—breast cancer	0.00296	0.00698	CbGbCtD
Nicardipine—CYP3A4—Paclitaxel—breast cancer	0.00245	0.00579	CbGbCtD
Nicardipine—CYP3A4—Irinotecan—breast cancer	0.00242	0.00571	CbGbCtD
Nicardipine—ABCB1—Doxorubicin—breast cancer	0.0022	0.00521	CbGbCtD
Nicardipine—CYP3A4—Vinblastine—breast cancer	0.00215	0.00508	CbGbCtD
Nicardipine—ABCB1—Methotrexate—breast cancer	0.00214	0.00504	CbGbCtD
Nicardipine—CYP2D6—Doxorubicin—breast cancer	0.00208	0.00491	CbGbCtD
Nicardipine—CYP3A4—Docetaxel—breast cancer	0.00177	0.00418	CbGbCtD
Nicardipine—CYP3A4—Doxorubicin—breast cancer	0.00132	0.00312	CbGbCtD
Nicardipine—CACNA2D1—mammary gland—breast cancer	0.00122	0.0251	CbGeAlD
Nicardipine—PDE1B—adipose tissue—breast cancer	0.000944	0.0195	CbGeAlD
Nicardipine—CALM3—mammary gland—breast cancer	0.000875	0.0181	CbGeAlD
Nicardipine—PDE1B—female reproductive system—breast cancer	0.000867	0.0179	CbGeAlD
Nicardipine—PDE1B—adrenal gland—breast cancer	0.000846	0.0175	CbGeAlD
Nicardipine—PDE1A—uterus—breast cancer	0.000809	0.0167	CbGeAlD
Nicardipine—PDE1A—adipose tissue—breast cancer	0.000791	0.0163	CbGeAlD
Nicardipine—PDE1B—endocrine gland—breast cancer	0.000734	0.0152	CbGeAlD
Nicardipine—PDE1A—female reproductive system—breast cancer	0.000727	0.015	CbGeAlD
Nicardipine—CALM3—nipple—breast cancer	0.000724	0.015	CbGeAlD
Nicardipine—PDE1A—adrenal gland—breast cancer	0.000709	0.0146	CbGeAlD
Nicardipine—CHRM5—epithelium—breast cancer	0.000699	0.0144	CbGeAlD
Nicardipine—CALM1—mammary gland—breast cancer	0.000684	0.0141	CbGeAlD
Nicardipine—CHRM5—skin of body—breast cancer	0.000665	0.0137	CbGeAlD
Nicardipine—PDE1A—female gonad—breast cancer	0.000661	0.0137	CbGeAlD
Nicardipine—ADRA1D—epithelium—breast cancer	0.000625	0.0129	CbGeAlD
Nicardipine—PDE1A—endocrine gland—breast cancer	0.000615	0.0127	CbGeAlD
Nicardipine—CACNB2—pituitary gland—breast cancer	0.000585	0.0121	CbGeAlD
Nicardipine—CYP2C8—mammary gland—breast cancer	0.00057	0.0118	CbGeAlD
Nicardipine—CALM2—nipple—breast cancer	0.000569	0.0117	CbGeAlD
Nicardipine—CALM1—nipple—breast cancer	0.000566	0.0117	CbGeAlD
Nicardipine—CACNA2D1—adipose tissue—breast cancer	0.000547	0.0113	CbGeAlD
Nicardipine—Nimodipine—AHR—breast cancer	0.000542	0.174	CrCbGaD
Nicardipine—CACNB2—adrenal gland—breast cancer	0.000523	0.0108	CbGeAlD
Nicardipine—CACNA1D—pituitary gland—breast cancer	0.000512	0.0106	CbGeAlD
Nicardipine—PDE1B—lymph node—breast cancer	0.000507	0.0105	CbGeAlD
Nicardipine—CYP2C9—mammary gland—breast cancer	0.000506	0.0105	CbGeAlD
Nicardipine—CACNA2D1—adrenal gland—breast cancer	0.000491	0.0101	CbGeAlD
Nicardipine—CACNA2D1—bone marrow—breast cancer	0.000475	0.00981	CbGeAlD
Nicardipine—CACNA1C—pituitary gland—breast cancer	0.000472	0.00975	CbGeAlD
Nicardipine—CACNA1C—adipose tissue—breast cancer	0.00047	0.00971	CbGeAlD
Nicardipine—CALM2—embryo—breast cancer	0.000469	0.00969	CbGeAlD
Nicardipine—CALM1—embryo—breast cancer	0.000467	0.00964	CbGeAlD
Nicardipine—ADRA1D—female reproductive system—breast cancer	0.000464	0.00959	CbGeAlD
Nicardipine—CACNA2D1—female gonad—breast cancer	0.000458	0.00946	CbGeAlD
Nicardipine—CACNA1D—adrenal gland—breast cancer	0.000457	0.00944	CbGeAlD
Nicardipine—CALM3—endometrium—breast cancer	0.000437	0.00903	CbGeAlD
Nicardipine—CACNA1C—female reproductive system—breast cancer	0.000432	0.00893	CbGeAlD
Nicardipine—CACNA2D1—endocrine gland—breast cancer	0.000426	0.00879	CbGeAlD
Nicardipine—PDE1A—lymph node—breast cancer	0.000425	0.00878	CbGeAlD
Nicardipine—CACNA1C—adrenal gland—breast cancer	0.000422	0.00871	CbGeAlD
Nicardipine—CALM3—uterus—breast cancer	0.000403	0.00832	CbGeAlD
Nicardipine—CACNA1D—endocrine gland—breast cancer	0.000396	0.00819	CbGeAlD
Nicardipine—CALM3—pituitary gland—breast cancer	0.000396	0.00817	CbGeAlD
Nicardipine—CALM3—adipose tissue—breast cancer	0.000394	0.00814	CbGeAlD
Nicardipine—ADRA1D—endocrine gland—breast cancer	0.000393	0.00812	CbGeAlD
Nicardipine—CALM2—epithelium—breast cancer	0.000383	0.00791	CbGeAlD
Nicardipine—CALM1—epithelium—breast cancer	0.000381	0.00787	CbGeAlD
Nicardipine—CACNA1C—endocrine gland—breast cancer	0.000366	0.00756	CbGeAlD
Nicardipine—CALM2—skin of body—breast cancer	0.000364	0.00752	CbGeAlD
Nicardipine—CALM1—skin of body—breast cancer	0.000362	0.00749	CbGeAlD
Nicardipine—ADRA1A—epithelium—breast cancer	0.000359	0.00742	CbGeAlD
Nicardipine—CALM3—adrenal gland—breast cancer	0.000353	0.0073	CbGeAlD
Nicardipine—CALM2—endometrium—breast cancer	0.000343	0.00709	CbGeAlD
Nicardipine—CALM3—bone marrow—breast cancer	0.000342	0.00706	CbGeAlD
Nicardipine—CALM1—endometrium—breast cancer	0.000342	0.00706	CbGeAlD
Nicardipine—CALM3—female gonad—breast cancer	0.00033	0.00681	CbGeAlD
Nicardipine—CHRM1—female reproductive system—breast cancer	0.000325	0.0067	CbGeAlD
Nicardipine—CALM2—uterus—breast cancer	0.000316	0.00653	CbGeAlD
Nicardipine—CHRM3—adipose tissue—breast cancer	0.000316	0.00653	CbGeAlD
Nicardipine—CALM1—uterus—breast cancer	0.000315	0.0065	CbGeAlD
Nicardipine—CACNB2—lymph node—breast cancer	0.000313	0.00647	CbGeAlD
Nicardipine—CALM2—pituitary gland—breast cancer	0.000311	0.00642	CbGeAlD
Nicardipine—CALM2—adipose tissue—breast cancer	0.000309	0.00639	CbGeAlD
Nicardipine—CALM1—pituitary gland—breast cancer	0.000309	0.00639	CbGeAlD
Nicardipine—CALM1—adipose tissue—breast cancer	0.000308	0.00636	CbGeAlD
Nicardipine—CHRM2—endocrine gland—breast cancer	0.000302	0.00623	CbGeAlD
Nicardipine—CACNA2D1—lymph node—breast cancer	0.000294	0.00608	CbGeAlD
Nicardipine—CHRM3—female reproductive system—breast cancer	0.000291	0.006	CbGeAlD
Nicardipine—ADRA1A—adipose tissue—breast cancer	0.00029	0.00599	CbGeAlD
Nicardipine—CYP2C8—endometrium—breast cancer	0.000285	0.00588	CbGeAlD
Nicardipine—CALM2—female reproductive system—breast cancer	0.000284	0.00587	CbGeAlD
Nicardipine—CALM1—female reproductive system—breast cancer	0.000283	0.00585	CbGeAlD
Nicardipine—CALM2—adrenal gland—breast cancer	0.000278	0.00573	CbGeAlD
Nicardipine—CALM1—adrenal gland—breast cancer	0.000276	0.0057	CbGeAlD
Nicardipine—CHRM1—endocrine gland—breast cancer	0.000275	0.00567	CbGeAlD
Nicardipine—CACNA1D—lymph node—breast cancer	0.000274	0.00566	CbGeAlD
Nicardipine—CYP2B6—skin of body—breast cancer	0.000271	0.00559	CbGeAlD
Nicardipine—CALM2—bone marrow—breast cancer	0.000268	0.00554	CbGeAlD
Nicardipine—CALM1—bone marrow—breast cancer	0.000267	0.00552	CbGeAlD
Nicardipine—CHRM3—female gonad—breast cancer	0.000264	0.00546	CbGeAlD
Nicardipine—ADRA1A—adrenal gland—breast cancer	0.00026	0.00538	CbGeAlD
Nicardipine—CALM2—female gonad—breast cancer	0.000259	0.00534	CbGeAlD
Nicardipine—CALM1—female gonad—breast cancer	0.000258	0.00532	CbGeAlD
Nicardipine—CYP2C8—pituitary gland—breast cancer	0.000257	0.00532	CbGeAlD
Nicardipine—CACNA1C—lymph node—breast cancer	0.000253	0.00522	CbGeAlD
Nicardipine—Clevidipine—BCHE—breast cancer	0.000246	0.0791	CrCbGaD
Nicardipine—CHRM3—endocrine gland—breast cancer	0.000246	0.00508	CbGeAlD
Nicardipine—CALM2—endocrine gland—breast cancer	0.000241	0.00497	CbGeAlD
Nicardipine—CALM1—endocrine gland—breast cancer	0.00024	0.00495	CbGeAlD
Nicardipine—CYP2C8—female reproductive system—breast cancer	0.000236	0.00487	CbGeAlD
Nicardipine—CYP3A5—adipose tissue—breast cancer	0.000231	0.00478	CbGeAlD
Nicardipine—CYP2C19—endocrine gland—breast cancer	0.000229	0.00472	CbGeAlD
Nicardipine—ADRA1A—endocrine gland—breast cancer	0.000226	0.00466	CbGeAlD
Nicardipine—CALM3—lymph node—breast cancer	0.000212	0.00437	CbGeAlD
Nicardipine—CYP2B6—female reproductive system—breast cancer	0.000211	0.00437	CbGeAlD
Nicardipine—CYP2C9—female reproductive system—breast cancer	0.000209	0.00432	CbGeAlD
Nicardipine—CYP2B6—adrenal gland—breast cancer	0.000206	0.00426	CbGeAlD
Nicardipine—CYP2C8—endocrine gland—breast cancer	0.000199	0.00412	CbGeAlD
Nicardipine—CYP2E1—female reproductive system—breast cancer	0.000198	0.0041	CbGeAlD
Nicardipine—CYP2E1—adrenal gland—breast cancer	0.000194	0.004	CbGeAlD
Nicardipine—CYP3A5—female gonad—breast cancer	0.000194	0.004	CbGeAlD
Nicardipine—ABCB1—embryo—breast cancer	0.000186	0.00385	CbGeAlD
Nicardipine—CYP3A5—endocrine gland—breast cancer	0.00018	0.00372	CbGeAlD
Nicardipine—CYP2B6—endocrine gland—breast cancer	0.000179	0.00369	CbGeAlD
Nicardipine—CYP2C9—endocrine gland—breast cancer	0.000177	0.00366	CbGeAlD
Nicardipine—Lercanidipine—CYP2D6—breast cancer	0.00017	0.0545	CrCbGaD
Nicardipine—CYP2E1—endocrine gland—breast cancer	0.000168	0.00347	CbGeAlD
Nicardipine—CALM2—lymph node—breast cancer	0.000166	0.00344	CbGeAlD
Nicardipine—CALM1—lymph node—breast cancer	0.000166	0.00342	CbGeAlD
Nicardipine—CYP3A4—female reproductive system—breast cancer	0.00016	0.0033	CbGeAlD
Nicardipine—CYP2D6—female reproductive system—breast cancer	0.000157	0.00324	CbGeAlD
Nicardipine—ABCB1—epithelium—breast cancer	0.000152	0.00314	CbGeAlD
Nicardipine—Lercanidipine—CYP3A4—breast cancer	0.000145	0.0468	CrCbGaD
Nicardipine—CYP2D6—female gonad—breast cancer	0.000143	0.00295	CbGeAlD
Nicardipine—Amlodipine—CYP1A1—breast cancer	0.00014	0.045	CrCbGaD
Nicardipine—ABCB1—endometrium—breast cancer	0.000136	0.00282	CbGeAlD
Nicardipine—CYP3A4—endocrine gland—breast cancer	0.000135	0.00279	CbGeAlD
Nicardipine—Clevidipine—CYP2D6—breast cancer	0.000135	0.0434	CrCbGaD
Nicardipine—CYP2D6—endocrine gland—breast cancer	0.000133	0.00275	CbGeAlD
Nicardipine—Isradipine—CYP3A4—breast cancer	0.000132	0.0423	CrCbGaD
Nicardipine—ABCB1—uterus—breast cancer	0.000126	0.0026	CbGeAlD
Nicardipine—Nifedipine—CYP1A1—breast cancer	0.000125	0.0403	CrCbGaD
Nicardipine—ABCB1—pituitary gland—breast cancer	0.000123	0.00255	CbGeAlD
Nicardipine—ABCB1—adipose tissue—breast cancer	0.000123	0.00254	CbGeAlD
Nicardipine—Clevidipine—CYP3A4—breast cancer	0.000116	0.0372	CrCbGaD
Nicardipine—ABCB1—female reproductive system—breast cancer	0.000113	0.00233	CbGeAlD
Nicardipine—Nisoldipine—CYP3A4—breast cancer	0.000111	0.0357	CrCbGaD
Nicardipine—ABCB1—adrenal gland—breast cancer	0.00011	0.00228	CbGeAlD
Nicardipine—Nimodipine—CYP3A4—breast cancer	0.000107	0.0345	CrCbGaD
Nicardipine—ABCB1—bone marrow—breast cancer	0.000107	0.0022	CbGeAlD
Nicardipine—Amlodipine—CYP2D6—breast cancer	0.000104	0.0335	CrCbGaD
Nicardipine—Nilvadipine—CYP3A4—breast cancer	0.000104	0.0334	CrCbGaD
Nicardipine—Nitrendipine—CYP3A4—breast cancer	0.000104	0.0334	CrCbGaD
Nicardipine—ABCB1—female gonad—breast cancer	0.000103	0.00212	CbGeAlD
Nicardipine—Felodipine—CYP2D6—breast cancer	9.64e-05	0.031	CrCbGaD
Nicardipine—ABCB1—endocrine gland—breast cancer	9.56e-05	0.00197	CbGeAlD
Nicardipine—Nifedipine—CYP2D6—breast cancer	9.32e-05	0.03	CrCbGaD
Nicardipine—Nisoldipine—ABCB1—breast cancer	9.24e-05	0.0297	CrCbGaD
Nicardipine—Amlodipine—CYP3A4—breast cancer	8.94e-05	0.0287	CrCbGaD
Nicardipine—Nitrendipine—ABCB1—breast cancer	8.64e-05	0.0278	CrCbGaD
Nicardipine—Felodipine—CYP3A4—breast cancer	8.26e-05	0.0266	CrCbGaD
Nicardipine—Nifedipine—CYP3A4—breast cancer	7.99e-05	0.0257	CrCbGaD
Nicardipine—Amlodipine—ABCB1—breast cancer	7.44e-05	0.0239	CrCbGaD
Nicardipine—Felodipine—ABCB1—breast cancer	6.88e-05	0.0221	CrCbGaD
Nicardipine—Nifedipine—ABCB1—breast cancer	6.65e-05	0.0214	CrCbGaD
Nicardipine—ABCB1—lymph node—breast cancer	6.61e-05	0.00137	CbGeAlD
Nicardipine—Asthenia—Gemcitabine—breast cancer	5.81e-05	0.000374	CcSEcCtD
Nicardipine—Myalgia—Capecitabine—breast cancer	5.81e-05	0.000374	CcSEcCtD
Nicardipine—Chest pain—Capecitabine—breast cancer	5.81e-05	0.000374	CcSEcCtD
Nicardipine—Arthralgia—Capecitabine—breast cancer	5.81e-05	0.000374	CcSEcCtD
Nicardipine—Pain—Paclitaxel—breast cancer	5.8e-05	0.000374	CcSEcCtD
Nicardipine—Constipation—Paclitaxel—breast cancer	5.8e-05	0.000374	CcSEcCtD
Nicardipine—Haematuria—Epirubicin—breast cancer	5.8e-05	0.000373	CcSEcCtD
Nicardipine—Confusional state—Docetaxel—breast cancer	5.8e-05	0.000373	CcSEcCtD
Nicardipine—Anxiety—Capecitabine—breast cancer	5.79e-05	0.000373	CcSEcCtD
Nicardipine—Oedema—Docetaxel—breast cancer	5.75e-05	0.00037	CcSEcCtD
Nicardipine—Discomfort—Capecitabine—breast cancer	5.74e-05	0.00037	CcSEcCtD
Nicardipine—Nausea—Thiotepa—breast cancer	5.72e-05	0.000368	CcSEcCtD
Nicardipine—Infection—Docetaxel—breast cancer	5.71e-05	0.000368	CcSEcCtD
Nicardipine—Sinusitis—Epirubicin—breast cancer	5.7e-05	0.000367	CcSEcCtD
Nicardipine—Diarrhoea—Mitoxantrone—breast cancer	5.69e-05	0.000367	CcSEcCtD
Nicardipine—Diarrhoea—Irinotecan—breast cancer	5.69e-05	0.000367	CcSEcCtD
Nicardipine—Dry mouth—Capecitabine—breast cancer	5.68e-05	0.000366	CcSEcCtD
Nicardipine—Shock—Docetaxel—breast cancer	5.66e-05	0.000364	CcSEcCtD
Nicardipine—Thrombocytopenia—Docetaxel—breast cancer	5.63e-05	0.000363	CcSEcCtD
Nicardipine—Visual impairment—Methotrexate—breast cancer	5.62e-05	0.000362	CcSEcCtD
Nicardipine—Confusional state—Capecitabine—breast cancer	5.61e-05	0.000362	CcSEcCtD
Nicardipine—Tachycardia—Docetaxel—breast cancer	5.61e-05	0.000361	CcSEcCtD
Nicardipine—Feeling abnormal—Paclitaxel—breast cancer	5.59e-05	0.00036	CcSEcCtD
Nicardipine—Oedema—Capecitabine—breast cancer	5.57e-05	0.000359	CcSEcCtD
Nicardipine—Gastrointestinal pain—Paclitaxel—breast cancer	5.55e-05	0.000357	CcSEcCtD
Nicardipine—Diarrhoea—Gemcitabine—breast cancer	5.54e-05	0.000357	CcSEcCtD
Nicardipine—Infection—Capecitabine—breast cancer	5.53e-05	0.000356	CcSEcCtD
Nicardipine—Dizziness—Irinotecan—breast cancer	5.5e-05	0.000354	CcSEcCtD
Nicardipine—Shock—Capecitabine—breast cancer	5.48e-05	0.000353	CcSEcCtD
Nicardipine—Rhinitis—Epirubicin—breast cancer	5.47e-05	0.000352	CcSEcCtD
Nicardipine—Conjunctivitis—Doxorubicin—breast cancer	5.47e-05	0.000352	CcSEcCtD
Nicardipine—Diarrhoea—Fluorouracil—breast cancer	5.45e-05	0.000351	CcSEcCtD
Nicardipine—Thrombocytopenia—Capecitabine—breast cancer	5.45e-05	0.000351	CcSEcCtD
Nicardipine—Tinnitus—Methotrexate—breast cancer	5.44e-05	0.00035	CcSEcCtD
Nicardipine—Tachycardia—Capecitabine—breast cancer	5.43e-05	0.00035	CcSEcCtD
Nicardipine—Hypoaesthesia—Epirubicin—breast cancer	5.43e-05	0.00035	CcSEcCtD
Nicardipine—Sweating—Doxorubicin—breast cancer	5.39e-05	0.000347	CcSEcCtD
Nicardipine—Hyperhidrosis—Capecitabine—breast cancer	5.38e-05	0.000347	CcSEcCtD
Nicardipine—Oedema peripheral—Epirubicin—breast cancer	5.38e-05	0.000346	CcSEcCtD
Nicardipine—Hypotension—Docetaxel—breast cancer	5.37e-05	0.000346	CcSEcCtD
Nicardipine—Haematuria—Doxorubicin—breast cancer	5.36e-05	0.000346	CcSEcCtD
Nicardipine—Abdominal pain—Paclitaxel—breast cancer	5.36e-05	0.000345	CcSEcCtD
Nicardipine—Body temperature increased—Paclitaxel—breast cancer	5.36e-05	0.000345	CcSEcCtD
Nicardipine—Vomiting—Irinotecan—breast cancer	5.29e-05	0.000341	CcSEcCtD
Nicardipine—Vomiting—Mitoxantrone—breast cancer	5.29e-05	0.000341	CcSEcCtD
Nicardipine—Sinusitis—Doxorubicin—breast cancer	5.28e-05	0.00034	CcSEcCtD
Nicardipine—Dizziness—Fluorouracil—breast cancer	5.27e-05	0.000339	CcSEcCtD
Nicardipine—Visual impairment—Epirubicin—breast cancer	5.26e-05	0.000339	CcSEcCtD
Nicardipine—Rash—Irinotecan—breast cancer	5.24e-05	0.000338	CcSEcCtD
Nicardipine—Rash—Mitoxantrone—breast cancer	5.24e-05	0.000338	CcSEcCtD
Nicardipine—Dermatitis—Mitoxantrone—breast cancer	5.24e-05	0.000337	CcSEcCtD
Nicardipine—Dermatitis—Irinotecan—breast cancer	5.24e-05	0.000337	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Docetaxel—breast cancer	5.24e-05	0.000337	CcSEcCtD
Nicardipine—Headache—Mitoxantrone—breast cancer	5.21e-05	0.000336	CcSEcCtD
Nicardipine—Headache—Irinotecan—breast cancer	5.21e-05	0.000336	CcSEcCtD
Nicardipine—Hypotension—Capecitabine—breast cancer	5.2e-05	0.000335	CcSEcCtD
Nicardipine—Insomnia—Docetaxel—breast cancer	5.2e-05	0.000335	CcSEcCtD
Nicardipine—Paraesthesia—Docetaxel—breast cancer	5.16e-05	0.000333	CcSEcCtD
Nicardipine—Vomiting—Gemcitabine—breast cancer	5.15e-05	0.000332	CcSEcCtD
Nicardipine—Dyspnoea—Docetaxel—breast cancer	5.12e-05	0.00033	CcSEcCtD
Nicardipine—Somnolence—Docetaxel—breast cancer	5.11e-05	0.000329	CcSEcCtD
Nicardipine—Rash—Gemcitabine—breast cancer	5.11e-05	0.000329	CcSEcCtD
Nicardipine—Dermatitis—Gemcitabine—breast cancer	5.1e-05	0.000329	CcSEcCtD
Nicardipine—Tinnitus—Epirubicin—breast cancer	5.09e-05	0.000328	CcSEcCtD
Nicardipine—Headache—Gemcitabine—breast cancer	5.07e-05	0.000327	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Capecitabine—breast cancer	5.07e-05	0.000327	CcSEcCtD
Nicardipine—Flushing—Epirubicin—breast cancer	5.06e-05	0.000326	CcSEcCtD
Nicardipine—Vomiting—Fluorouracil—breast cancer	5.06e-05	0.000326	CcSEcCtD
Nicardipine—Rhinitis—Doxorubicin—breast cancer	5.06e-05	0.000326	CcSEcCtD
Nicardipine—Dyspepsia—Docetaxel—breast cancer	5.06e-05	0.000326	CcSEcCtD
Nicardipine—Insomnia—Capecitabine—breast cancer	5.03e-05	0.000324	CcSEcCtD
Nicardipine—Hypoaesthesia—Doxorubicin—breast cancer	5.02e-05	0.000324	CcSEcCtD
Nicardipine—Rash—Fluorouracil—breast cancer	5.02e-05	0.000324	CcSEcCtD
Nicardipine—Dermatitis—Fluorouracil—breast cancer	5.02e-05	0.000323	CcSEcCtD
Nicardipine—Paraesthesia—Capecitabine—breast cancer	5e-05	0.000322	CcSEcCtD
Nicardipine—Hypersensitivity—Paclitaxel—breast cancer	5e-05	0.000322	CcSEcCtD
Nicardipine—Headache—Fluorouracil—breast cancer	4.99e-05	0.000321	CcSEcCtD
Nicardipine—Oedema peripheral—Doxorubicin—breast cancer	4.97e-05	0.00032	CcSEcCtD
Nicardipine—Dyspnoea—Capecitabine—breast cancer	4.96e-05	0.00032	CcSEcCtD
Nicardipine—Nausea—Mitoxantrone—breast cancer	4.94e-05	0.000318	CcSEcCtD
Nicardipine—Nausea—Irinotecan—breast cancer	4.94e-05	0.000318	CcSEcCtD
Nicardipine—Pain—Docetaxel—breast cancer	4.92e-05	0.000317	CcSEcCtD
Nicardipine—Constipation—Docetaxel—breast cancer	4.92e-05	0.000317	CcSEcCtD
Nicardipine—Dyspepsia—Capecitabine—breast cancer	4.9e-05	0.000316	CcSEcCtD
Nicardipine—Visual impairment—Doxorubicin—breast cancer	4.87e-05	0.000314	CcSEcCtD
Nicardipine—Asthenia—Paclitaxel—breast cancer	4.87e-05	0.000313	CcSEcCtD
Nicardipine—Nausea—Gemcitabine—breast cancer	4.81e-05	0.00031	CcSEcCtD
Nicardipine—Vision blurred—Methotrexate—breast cancer	4.78e-05	0.000308	CcSEcCtD
Nicardipine—Pain—Capecitabine—breast cancer	4.76e-05	0.000307	CcSEcCtD
Nicardipine—Constipation—Capecitabine—breast cancer	4.76e-05	0.000307	CcSEcCtD
Nicardipine—Feeling abnormal—Docetaxel—breast cancer	4.74e-05	0.000305	CcSEcCtD
Nicardipine—Nausea—Fluorouracil—breast cancer	4.73e-05	0.000305	CcSEcCtD
Nicardipine—Ill-defined disorder—Methotrexate—breast cancer	4.71e-05	0.000303	CcSEcCtD
Nicardipine—Tinnitus—Doxorubicin—breast cancer	4.71e-05	0.000303	CcSEcCtD
Nicardipine—Gastrointestinal pain—Docetaxel—breast cancer	4.7e-05	0.000303	CcSEcCtD
Nicardipine—Flushing—Doxorubicin—breast cancer	4.69e-05	0.000302	CcSEcCtD
Nicardipine—Tension—Epirubicin—breast cancer	4.66e-05	0.0003	CcSEcCtD
Nicardipine—Diarrhoea—Paclitaxel—breast cancer	4.64e-05	0.000299	CcSEcCtD
Nicardipine—Nervousness—Epirubicin—breast cancer	4.61e-05	0.000297	CcSEcCtD
Nicardipine—Feeling abnormal—Capecitabine—breast cancer	4.59e-05	0.000295	CcSEcCtD
Nicardipine—Malaise—Methotrexate—breast cancer	4.58e-05	0.000295	CcSEcCtD
Nicardipine—Vertigo—Methotrexate—breast cancer	4.56e-05	0.000294	CcSEcCtD
Nicardipine—Gastrointestinal pain—Capecitabine—breast cancer	4.55e-05	0.000293	CcSEcCtD
Nicardipine—Abdominal pain—Docetaxel—breast cancer	4.54e-05	0.000293	CcSEcCtD
Nicardipine—Body temperature increased—Docetaxel—breast cancer	4.54e-05	0.000293	CcSEcCtD
Nicardipine—Dizziness—Paclitaxel—breast cancer	4.48e-05	0.000289	CcSEcCtD
Nicardipine—Vision blurred—Epirubicin—breast cancer	4.48e-05	0.000288	CcSEcCtD
Nicardipine—Ill-defined disorder—Epirubicin—breast cancer	4.41e-05	0.000284	CcSEcCtD
Nicardipine—Abdominal pain—Capecitabine—breast cancer	4.4e-05	0.000283	CcSEcCtD
Nicardipine—Body temperature increased—Capecitabine—breast cancer	4.4e-05	0.000283	CcSEcCtD
Nicardipine—Agitation—Epirubicin—breast cancer	4.37e-05	0.000281	CcSEcCtD
Nicardipine—Chest pain—Methotrexate—breast cancer	4.32e-05	0.000278	CcSEcCtD
Nicardipine—Arthralgia—Methotrexate—breast cancer	4.32e-05	0.000278	CcSEcCtD
Nicardipine—Myalgia—Methotrexate—breast cancer	4.32e-05	0.000278	CcSEcCtD
Nicardipine—Tension—Doxorubicin—breast cancer	4.31e-05	0.000278	CcSEcCtD
Nicardipine—Vomiting—Paclitaxel—breast cancer	4.31e-05	0.000278	CcSEcCtD
Nicardipine—Malaise—Epirubicin—breast cancer	4.28e-05	0.000276	CcSEcCtD
Nicardipine—Rash—Paclitaxel—breast cancer	4.28e-05	0.000275	CcSEcCtD
Nicardipine—Dermatitis—Paclitaxel—breast cancer	4.27e-05	0.000275	CcSEcCtD
Nicardipine—Discomfort—Methotrexate—breast cancer	4.27e-05	0.000275	CcSEcCtD
Nicardipine—Nervousness—Doxorubicin—breast cancer	4.27e-05	0.000275	CcSEcCtD
Nicardipine—Vertigo—Epirubicin—breast cancer	4.27e-05	0.000275	CcSEcCtD
Nicardipine—Syncope—Epirubicin—breast cancer	4.26e-05	0.000274	CcSEcCtD
Nicardipine—Headache—Paclitaxel—breast cancer	4.25e-05	0.000274	CcSEcCtD
Nicardipine—Hypersensitivity—Docetaxel—breast cancer	4.24e-05	0.000273	CcSEcCtD
Nicardipine—Palpitations—Epirubicin—breast cancer	4.2e-05	0.00027	CcSEcCtD
Nicardipine—Confusional state—Methotrexate—breast cancer	4.18e-05	0.000269	CcSEcCtD
Nicardipine—Loss of consciousness—Epirubicin—breast cancer	4.18e-05	0.000269	CcSEcCtD
Nicardipine—Vision blurred—Doxorubicin—breast cancer	4.14e-05	0.000267	CcSEcCtD
Nicardipine—Asthenia—Docetaxel—breast cancer	4.12e-05	0.000266	CcSEcCtD
Nicardipine—Infection—Methotrexate—breast cancer	4.12e-05	0.000265	CcSEcCtD
Nicardipine—Hypertension—Epirubicin—breast cancer	4.1e-05	0.000264	CcSEcCtD
Nicardipine—Hypersensitivity—Capecitabine—breast cancer	4.1e-05	0.000264	CcSEcCtD
Nicardipine—Ill-defined disorder—Doxorubicin—breast cancer	4.08e-05	0.000263	CcSEcCtD
Nicardipine—Thrombocytopenia—Methotrexate—breast cancer	4.06e-05	0.000261	CcSEcCtD
Nicardipine—Arthralgia—Epirubicin—breast cancer	4.04e-05	0.000261	CcSEcCtD
Nicardipine—Chest pain—Epirubicin—breast cancer	4.04e-05	0.000261	CcSEcCtD
Nicardipine—Myalgia—Epirubicin—breast cancer	4.04e-05	0.000261	CcSEcCtD
Nicardipine—Agitation—Doxorubicin—breast cancer	4.04e-05	0.00026	CcSEcCtD
Nicardipine—Anxiety—Epirubicin—breast cancer	4.03e-05	0.00026	CcSEcCtD
Nicardipine—Nausea—Paclitaxel—breast cancer	4.03e-05	0.00026	CcSEcCtD
Nicardipine—Hyperhidrosis—Methotrexate—breast cancer	4.01e-05	0.000258	CcSEcCtD
Nicardipine—Discomfort—Epirubicin—breast cancer	4e-05	0.000257	CcSEcCtD
Nicardipine—Asthenia—Capecitabine—breast cancer	3.99e-05	0.000257	CcSEcCtD
Nicardipine—Malaise—Doxorubicin—breast cancer	3.96e-05	0.000255	CcSEcCtD
Nicardipine—Dry mouth—Epirubicin—breast cancer	3.96e-05	0.000255	CcSEcCtD
Nicardipine—Vertigo—Doxorubicin—breast cancer	3.95e-05	0.000254	CcSEcCtD
Nicardipine—Syncope—Doxorubicin—breast cancer	3.94e-05	0.000254	CcSEcCtD
Nicardipine—Diarrhoea—Docetaxel—breast cancer	3.93e-05	0.000253	CcSEcCtD
Nicardipine—Confusional state—Epirubicin—breast cancer	3.91e-05	0.000252	CcSEcCtD
Nicardipine—Palpitations—Doxorubicin—breast cancer	3.88e-05	0.00025	CcSEcCtD
Nicardipine—Oedema—Epirubicin—breast cancer	3.88e-05	0.00025	CcSEcCtD
Nicardipine—Hypotension—Methotrexate—breast cancer	3.87e-05	0.000249	CcSEcCtD
Nicardipine—Loss of consciousness—Doxorubicin—breast cancer	3.86e-05	0.000249	CcSEcCtD
Nicardipine—Infection—Epirubicin—breast cancer	3.85e-05	0.000248	CcSEcCtD
Nicardipine—Shock—Epirubicin—breast cancer	3.81e-05	0.000246	CcSEcCtD
Nicardipine—Diarrhoea—Capecitabine—breast cancer	3.81e-05	0.000245	CcSEcCtD
Nicardipine—Dizziness—Docetaxel—breast cancer	3.8e-05	0.000245	CcSEcCtD
Nicardipine—Thrombocytopenia—Epirubicin—breast cancer	3.8e-05	0.000245	CcSEcCtD
Nicardipine—Hypertension—Doxorubicin—breast cancer	3.8e-05	0.000245	CcSEcCtD
Nicardipine—Tachycardia—Epirubicin—breast cancer	3.78e-05	0.000244	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Methotrexate—breast cancer	3.77e-05	0.000243	CcSEcCtD
Nicardipine—Hyperhidrosis—Epirubicin—breast cancer	3.75e-05	0.000241	CcSEcCtD
Nicardipine—Insomnia—Methotrexate—breast cancer	3.75e-05	0.000241	CcSEcCtD
Nicardipine—Arthralgia—Doxorubicin—breast cancer	3.74e-05	0.000241	CcSEcCtD
Nicardipine—Myalgia—Doxorubicin—breast cancer	3.74e-05	0.000241	CcSEcCtD
Nicardipine—Chest pain—Doxorubicin—breast cancer	3.74e-05	0.000241	CcSEcCtD
Nicardipine—Anxiety—Doxorubicin—breast cancer	3.73e-05	0.00024	CcSEcCtD
Nicardipine—Paraesthesia—Methotrexate—breast cancer	3.72e-05	0.00024	CcSEcCtD
Nicardipine—Discomfort—Doxorubicin—breast cancer	3.7e-05	0.000238	CcSEcCtD
Nicardipine—Dyspnoea—Methotrexate—breast cancer	3.69e-05	0.000238	CcSEcCtD
Nicardipine—Somnolence—Methotrexate—breast cancer	3.68e-05	0.000237	CcSEcCtD
Nicardipine—Dizziness—Capecitabine—breast cancer	3.68e-05	0.000237	CcSEcCtD
Nicardipine—Dry mouth—Doxorubicin—breast cancer	3.66e-05	0.000236	CcSEcCtD
Nicardipine—Vomiting—Docetaxel—breast cancer	3.65e-05	0.000235	CcSEcCtD
Nicardipine—Dyspepsia—Methotrexate—breast cancer	3.65e-05	0.000235	CcSEcCtD
Nicardipine—Rash—Docetaxel—breast cancer	3.62e-05	0.000234	CcSEcCtD
Nicardipine—Hypotension—Epirubicin—breast cancer	3.62e-05	0.000233	CcSEcCtD
Nicardipine—Dermatitis—Docetaxel—breast cancer	3.62e-05	0.000233	CcSEcCtD
Nicardipine—Confusional state—Doxorubicin—breast cancer	3.62e-05	0.000233	CcSEcCtD
Nicardipine—Headache—Docetaxel—breast cancer	3.6e-05	0.000232	CcSEcCtD
Nicardipine—Oedema—Doxorubicin—breast cancer	3.59e-05	0.000231	CcSEcCtD
Nicardipine—Infection—Doxorubicin—breast cancer	3.56e-05	0.00023	CcSEcCtD
Nicardipine—Pain—Methotrexate—breast cancer	3.54e-05	0.000228	CcSEcCtD
Nicardipine—Vomiting—Capecitabine—breast cancer	3.54e-05	0.000228	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Epirubicin—breast cancer	3.53e-05	0.000228	CcSEcCtD
Nicardipine—Shock—Doxorubicin—breast cancer	3.53e-05	0.000227	CcSEcCtD
Nicardipine—Thrombocytopenia—Doxorubicin—breast cancer	3.51e-05	0.000226	CcSEcCtD
Nicardipine—Rash—Capecitabine—breast cancer	3.51e-05	0.000226	CcSEcCtD
Nicardipine—Insomnia—Epirubicin—breast cancer	3.51e-05	0.000226	CcSEcCtD
Nicardipine—Dermatitis—Capecitabine—breast cancer	3.51e-05	0.000226	CcSEcCtD
Nicardipine—Tachycardia—Doxorubicin—breast cancer	3.5e-05	0.000226	CcSEcCtD
Nicardipine—Headache—Capecitabine—breast cancer	3.49e-05	0.000225	CcSEcCtD
Nicardipine—Paraesthesia—Epirubicin—breast cancer	3.48e-05	0.000224	CcSEcCtD
Nicardipine—Hyperhidrosis—Doxorubicin—breast cancer	3.47e-05	0.000223	CcSEcCtD
Nicardipine—Dyspnoea—Epirubicin—breast cancer	3.46e-05	0.000223	CcSEcCtD
Nicardipine—Somnolence—Epirubicin—breast cancer	3.45e-05	0.000222	CcSEcCtD
Nicardipine—Nausea—Docetaxel—breast cancer	3.41e-05	0.00022	CcSEcCtD
Nicardipine—Feeling abnormal—Methotrexate—breast cancer	3.41e-05	0.00022	CcSEcCtD
Nicardipine—Dyspepsia—Epirubicin—breast cancer	3.41e-05	0.00022	CcSEcCtD
Nicardipine—Gastrointestinal pain—Methotrexate—breast cancer	3.39e-05	0.000218	CcSEcCtD
Nicardipine—Hypotension—Doxorubicin—breast cancer	3.35e-05	0.000216	CcSEcCtD
Nicardipine—Constipation—Epirubicin—breast cancer	3.32e-05	0.000214	CcSEcCtD
Nicardipine—Pain—Epirubicin—breast cancer	3.32e-05	0.000214	CcSEcCtD
Nicardipine—Nausea—Capecitabine—breast cancer	3.31e-05	0.000213	CcSEcCtD
Nicardipine—Abdominal pain—Methotrexate—breast cancer	3.28e-05	0.000211	CcSEcCtD
Nicardipine—Body temperature increased—Methotrexate—breast cancer	3.28e-05	0.000211	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.27e-05	0.000211	CcSEcCtD
Nicardipine—Insomnia—Doxorubicin—breast cancer	3.24e-05	0.000209	CcSEcCtD
Nicardipine—Paraesthesia—Doxorubicin—breast cancer	3.22e-05	0.000208	CcSEcCtD
Nicardipine—Dyspnoea—Doxorubicin—breast cancer	3.2e-05	0.000206	CcSEcCtD
Nicardipine—Feeling abnormal—Epirubicin—breast cancer	3.19e-05	0.000206	CcSEcCtD
Nicardipine—Somnolence—Doxorubicin—breast cancer	3.19e-05	0.000205	CcSEcCtD
Nicardipine—Gastrointestinal pain—Epirubicin—breast cancer	3.17e-05	0.000204	CcSEcCtD
Nicardipine—Dyspepsia—Doxorubicin—breast cancer	3.16e-05	0.000203	CcSEcCtD
Nicardipine—Pain—Doxorubicin—breast cancer	3.07e-05	0.000198	CcSEcCtD
Nicardipine—Constipation—Doxorubicin—breast cancer	3.07e-05	0.000198	CcSEcCtD
Nicardipine—Abdominal pain—Epirubicin—breast cancer	3.06e-05	0.000197	CcSEcCtD
Nicardipine—Body temperature increased—Epirubicin—breast cancer	3.06e-05	0.000197	CcSEcCtD
Nicardipine—Hypersensitivity—Methotrexate—breast cancer	3.05e-05	0.000197	CcSEcCtD
Nicardipine—Asthenia—Methotrexate—breast cancer	2.97e-05	0.000192	CcSEcCtD
Nicardipine—Feeling abnormal—Doxorubicin—breast cancer	2.96e-05	0.00019	CcSEcCtD
Nicardipine—Gastrointestinal pain—Doxorubicin—breast cancer	2.93e-05	0.000189	CcSEcCtD
Nicardipine—Hypersensitivity—Epirubicin—breast cancer	2.86e-05	0.000184	CcSEcCtD
Nicardipine—Body temperature increased—Doxorubicin—breast cancer	2.84e-05	0.000183	CcSEcCtD
Nicardipine—Abdominal pain—Doxorubicin—breast cancer	2.84e-05	0.000183	CcSEcCtD
Nicardipine—Diarrhoea—Methotrexate—breast cancer	2.83e-05	0.000183	CcSEcCtD
Nicardipine—Asthenia—Epirubicin—breast cancer	2.78e-05	0.000179	CcSEcCtD
Nicardipine—Dizziness—Methotrexate—breast cancer	2.74e-05	0.000177	CcSEcCtD
Nicardipine—Diarrhoea—Epirubicin—breast cancer	2.65e-05	0.000171	CcSEcCtD
Nicardipine—Hypersensitivity—Doxorubicin—breast cancer	2.64e-05	0.00017	CcSEcCtD
Nicardipine—Vomiting—Methotrexate—breast cancer	2.63e-05	0.00017	CcSEcCtD
Nicardipine—Rash—Methotrexate—breast cancer	2.61e-05	0.000168	CcSEcCtD
Nicardipine—Dermatitis—Methotrexate—breast cancer	2.61e-05	0.000168	CcSEcCtD
Nicardipine—Headache—Methotrexate—breast cancer	2.6e-05	0.000167	CcSEcCtD
Nicardipine—Asthenia—Doxorubicin—breast cancer	2.57e-05	0.000166	CcSEcCtD
Nicardipine—Dizziness—Epirubicin—breast cancer	2.56e-05	0.000165	CcSEcCtD
Nicardipine—Vomiting—Epirubicin—breast cancer	2.47e-05	0.000159	CcSEcCtD
Nicardipine—Nausea—Methotrexate—breast cancer	2.46e-05	0.000159	CcSEcCtD
Nicardipine—Diarrhoea—Doxorubicin—breast cancer	2.45e-05	0.000158	CcSEcCtD
Nicardipine—Rash—Epirubicin—breast cancer	2.44e-05	0.000158	CcSEcCtD
Nicardipine—Dermatitis—Epirubicin—breast cancer	2.44e-05	0.000157	CcSEcCtD
Nicardipine—Headache—Epirubicin—breast cancer	2.43e-05	0.000156	CcSEcCtD
Nicardipine—Dizziness—Doxorubicin—breast cancer	2.37e-05	0.000153	CcSEcCtD
Nicardipine—Nausea—Epirubicin—breast cancer	2.3e-05	0.000148	CcSEcCtD
Nicardipine—Vomiting—Doxorubicin—breast cancer	2.28e-05	0.000147	CcSEcCtD
Nicardipine—Rash—Doxorubicin—breast cancer	2.26e-05	0.000146	CcSEcCtD
Nicardipine—Dermatitis—Doxorubicin—breast cancer	2.26e-05	0.000146	CcSEcCtD
Nicardipine—Headache—Doxorubicin—breast cancer	2.25e-05	0.000145	CcSEcCtD
Nicardipine—Nausea—Doxorubicin—breast cancer	2.13e-05	0.000137	CcSEcCtD
Nicardipine—CALM1—Signaling Pathways—RELA—breast cancer	8.12e-07	5.51e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—NOS3—breast cancer	8.08e-07	5.48e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GSTM1—breast cancer	8.08e-07	5.48e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—NCOR1—breast cancer	8.08e-07	5.48e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PLA2G4A—breast cancer	8.08e-07	5.48e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	8.07e-07	5.47e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ERBB2—breast cancer	8.07e-07	5.47e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ERBB2—breast cancer	8.07e-07	5.47e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CD—breast cancer	8.07e-07	5.47e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	8.03e-07	5.45e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CD—breast cancer	8e-07	5.42e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—breast cancer	7.99e-07	5.42e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—breast cancer	7.99e-07	5.42e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CB—breast cancer	7.96e-07	5.4e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MTOR—breast cancer	7.96e-07	5.4e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CB—breast cancer	7.96e-07	5.4e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MTOR—breast cancer	7.96e-07	5.4e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—ALB—breast cancer	7.96e-07	5.4e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCL8—breast cancer	7.91e-07	5.37e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—SRC—breast cancer	7.9e-07	5.36e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HRAS—breast cancer	7.9e-07	5.36e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—breast cancer	7.9e-07	5.36e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ALB—breast cancer	7.89e-07	5.35e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—SRC—breast cancer	7.88e-07	5.34e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HRAS—breast cancer	7.86e-07	5.33e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—breast cancer	7.85e-07	5.32e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	7.83e-07	5.31e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—SRC—breast cancer	7.8e-07	5.29e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—KRAS—breast cancer	7.8e-07	5.29e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—SRC—breast cancer	7.78e-07	5.28e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—breast cancer	7.77e-07	5.27e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—PIK3CA—breast cancer	7.76e-07	5.26e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GPX1—breast cancer	7.74e-07	5.25e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDKN1B—breast cancer	7.73e-07	5.24e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—breast cancer	7.7e-07	5.22e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—breast cancer	7.68e-07	5.21e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—breast cancer	7.67e-07	5.2e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CYP1A1—breast cancer	7.66e-07	5.19e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCL8—breast cancer	7.65e-07	5.19e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCL8—breast cancer	7.65e-07	5.19e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CB—breast cancer	7.64e-07	5.18e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STAT3—breast cancer	7.62e-07	5.17e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—NOS3—breast cancer	7.62e-07	5.17e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HRAS—breast cancer	7.6e-07	5.16e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HRAS—breast cancer	7.6e-07	5.16e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—breast cancer	7.6e-07	5.15e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STAT3—breast cancer	7.6e-07	5.15e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ERCC2—breast cancer	7.6e-07	5.15e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	7.58e-07	5.14e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—breast cancer	7.57e-07	5.14e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CASP3—breast cancer	7.57e-07	5.14e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—breast cancer	7.56e-07	5.13e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2—breast cancer	7.56e-07	5.13e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—NOS3—breast cancer	7.55e-07	5.12e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—KRAS—breast cancer	7.55e-07	5.12e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—KRAS—breast cancer	7.55e-07	5.12e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STAT3—breast cancer	7.53e-07	5.1e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—breast cancer	7.52e-07	5.1e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—PIK3CA—breast cancer	7.51e-07	5.09e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—PIK3CA—breast cancer	7.51e-07	5.09e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STAT3—breast cancer	7.5e-07	5.09e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDKN1B—breast cancer	7.47e-07	5.07e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDKN1B—breast cancer	7.47e-07	5.07e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CB—breast cancer	7.46e-07	5.06e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HRAS—breast cancer	7.43e-07	5.04e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTEN—breast cancer	7.4e-07	5.02e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—breast cancer	7.39e-07	5.01e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCND1—breast cancer	7.37e-07	5e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—JUN—breast cancer	7.35e-07	4.99e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CASP3—breast cancer	7.32e-07	4.97e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CASP3—breast cancer	7.32e-07	4.97e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2—breast cancer	7.31e-07	4.96e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2—breast cancer	7.31e-07	4.96e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CTNNB1—breast cancer	7.3e-07	4.95e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—breast cancer	7.29e-07	4.94e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MAPK3—breast cancer	7.28e-07	4.94e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—breast cancer	7.28e-07	4.94e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6—breast cancer	7.28e-07	4.94e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MAPK3—breast cancer	7.26e-07	4.92e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KRAS—breast cancer	7.25e-07	4.92e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MAPK3—breast cancer	7.19e-07	4.88e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HRAS—breast cancer	7.18e-07	4.87e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	7.17e-07	4.86e-06	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PIK3CA—breast cancer	7.17e-07	4.86e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—PIK3CA—breast cancer	7.17e-07	4.86e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—breast cancer	7.16e-07	4.85e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—MTHFR—breast cancer	7.14e-07	4.84e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDKN1A—breast cancer	7.13e-07	4.84e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCND1—breast cancer	7.13e-07	4.84e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCND1—breast cancer	7.13e-07	4.84e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—JUN—breast cancer	7.11e-07	4.83e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—JUN—breast cancer	7.11e-07	4.83e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PTEN—breast cancer	7.11e-07	4.82e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6—breast cancer	7.11e-07	4.82e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—breast cancer	7.08e-07	4.8e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TGFB1—breast cancer	7.07e-07	4.79e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—breast cancer	7.06e-07	4.79e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CTNNB1—breast cancer	7.06e-07	4.79e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CTNNB1—breast cancer	7.06e-07	4.79e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TGFB1—breast cancer	7.04e-07	4.78e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CB—breast cancer	7.03e-07	4.77e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—breast cancer	6.99e-07	4.74e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—breast cancer	6.98e-07	4.73e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TGFB1—breast cancer	6.98e-07	4.73e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—breast cancer	6.97e-07	4.73e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CB—breast cancer	6.97e-07	4.73e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—breast cancer	6.97e-07	4.73e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK8—breast cancer	6.96e-07	4.72e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	6.96e-07	4.72e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HRAS—breast cancer	6.95e-07	4.71e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HRAS—breast cancer	6.95e-07	4.71e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—breast cancer	6.94e-07	4.71e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—PIK3CA—breast cancer	6.93e-07	4.7e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—PIK3CA—breast cancer	6.93e-07	4.7e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—breast cancer	6.93e-07	4.7e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—breast cancer	6.92e-07	4.69e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—breast cancer	6.92e-07	4.69e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—breast cancer	6.91e-07	4.68e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—breast cancer	6.91e-07	4.68e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDKN1A—breast cancer	6.9e-07	4.68e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDKN1A—breast cancer	6.9e-07	4.68e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PTEN—breast cancer	6.88e-07	4.67e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PTEN—breast cancer	6.88e-07	4.67e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—breast cancer	6.87e-07	4.66e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—breast cancer	6.84e-07	4.64e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—breast cancer	6.82e-07	4.63e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK8—breast cancer	6.73e-07	4.57e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK8—breast cancer	6.73e-07	4.57e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—breast cancer	6.71e-07	4.55e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—breast cancer	6.71e-07	4.55e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	6.66e-07	4.52e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—breast cancer	6.65e-07	4.51e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—breast cancer	6.65e-07	4.51e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—HRAS—breast cancer	6.63e-07	4.5e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTEN—breast cancer	6.61e-07	4.48e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SRC—breast cancer	6.6e-07	4.47e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CAV1—breast cancer	6.59e-07	4.47e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—breast cancer	6.56e-07	4.45e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KRAS—breast cancer	6.55e-07	4.44e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KRAS—breast cancer	6.52e-07	4.42e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KRAS—breast cancer	6.46e-07	4.38e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTEN—breast cancer	6.45e-07	4.37e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—breast cancer	6.45e-07	4.37e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KRAS—breast cancer	6.44e-07	4.37e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—breast cancer	6.43e-07	4.36e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—HRAS—breast cancer	6.41e-07	4.35e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—HRAS—breast cancer	6.41e-07	4.35e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SRC—breast cancer	6.38e-07	4.33e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SRC—breast cancer	6.38e-07	4.33e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STAT3—breast cancer	6.36e-07	4.31e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—breast cancer	6.35e-07	4.3e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—breast cancer	6.34e-07	4.3e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—breast cancer	6.22e-07	4.22e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—breast cancer	6.22e-07	4.22e-06	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PIK3CA—breast cancer	6.17e-07	4.18e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HRAS—breast cancer	6.17e-07	4.18e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STAT3—breast cancer	6.15e-07	4.17e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STAT3—breast cancer	6.15e-07	4.17e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—breast cancer	6.14e-07	4.16e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—breast cancer	6.14e-07	4.16e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—breast cancer	6.13e-07	4.16e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—breast cancer	6.13e-07	4.16e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK3—breast cancer	6.08e-07	4.12e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTEN—breast cancer	6.08e-07	4.12e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PIK3CA—breast cancer	6.04e-07	4.1e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PIK3CA—breast cancer	6.03e-07	4.09e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTEN—breast cancer	6.02e-07	4.09e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	6.01e-07	4.08e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PIK3CA—breast cancer	6e-07	4.07e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CG—breast cancer	6e-07	4.07e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PIK3CA—breast cancer	5.99e-07	4.07e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	5.94e-07	4.03e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	5.92e-07	4.01e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—breast cancer	5.91e-07	4.01e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6—breast cancer	5.9e-07	4e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TGFB1—breast cancer	5.9e-07	4e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK3—breast cancer	5.88e-07	3.99e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK3—breast cancer	5.88e-07	3.99e-06	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—breast cancer	5.86e-07	3.97e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—breast cancer	5.85e-07	3.97e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—breast cancer	5.82e-07	3.95e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PIK3CA—breast cancer	5.81e-07	3.94e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PIK3CA—breast cancer	5.81e-07	3.94e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—breast cancer	5.8e-07	3.93e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—breast cancer	5.78e-07	3.92e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—breast cancer	5.74e-07	3.89e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—breast cancer	5.73e-07	3.88e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—breast cancer	5.72e-07	3.88e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—breast cancer	5.72e-07	3.88e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TGFB1—breast cancer	5.7e-07	3.87e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TGFB1—breast cancer	5.7e-07	3.87e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—breast cancer	5.66e-07	3.84e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—breast cancer	5.66e-07	3.84e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—breast cancer	5.59e-07	3.79e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—breast cancer	5.59e-07	3.79e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HRAS—breast cancer	5.56e-07	3.77e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HRAS—breast cancer	5.55e-07	3.76e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HRAS—breast cancer	5.49e-07	3.72e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HRAS—breast cancer	5.48e-07	3.71e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KRAS—breast cancer	5.46e-07	3.7e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—breast cancer	5.44e-07	3.69e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6—breast cancer	5.32e-07	3.61e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—breast cancer	5.31e-07	3.6e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KRAS—breast cancer	5.28e-07	3.58e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KRAS—breast cancer	5.28e-07	3.58e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CD—breast cancer	5.27e-07	3.58e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—breast cancer	5.26e-07	3.56e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—breast cancer	5.24e-07	3.56e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CA—breast cancer	5.22e-07	3.54e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ALB—breast cancer	5.21e-07	3.53e-06	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—breast cancer	5.04e-07	3.42e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CA—breast cancer	5.02e-07	3.4e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—NOS3—breast cancer	4.98e-07	3.38e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—breast cancer	4.93e-07	3.35e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—breast cancer	4.92e-07	3.34e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—breast cancer	4.91e-07	3.33e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—breast cancer	4.9e-07	3.33e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—breast cancer	4.9e-07	3.32e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—breast cancer	4.86e-07	3.29e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CA—breast cancer	4.85e-07	3.29e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CA—breast cancer	4.85e-07	3.29e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—breast cancer	4.85e-07	3.29e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—breast cancer	4.84e-07	3.28e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—breast cancer	4.74e-07	3.22e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—breast cancer	4.74e-07	3.22e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—breast cancer	4.7e-07	3.19e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—breast cancer	4.7e-07	3.19e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CA—breast cancer	4.66e-07	3.16e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HRAS—breast cancer	4.64e-07	3.15e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CB—breast cancer	4.6e-07	3.12e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—breast cancer	4.56e-07	3.09e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CA—breast cancer	4.55e-07	3.08e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HRAS—breast cancer	4.49e-07	3.05e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HRAS—breast cancer	4.49e-07	3.05e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—breast cancer	4.44e-07	3.01e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—breast cancer	4.3e-07	2.92e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—breast cancer	4.3e-07	2.92e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CA—breast cancer	4.29e-07	2.91e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—breast cancer	4.27e-07	2.89e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CA—breast cancer	4.25e-07	2.88e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—breast cancer	4.1e-07	2.78e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTEN—breast cancer	3.97e-07	2.69e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—breast cancer	3.97e-07	2.69e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—breast cancer	3.97e-07	2.69e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—breast cancer	3.81e-07	2.58e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—breast cancer	3.72e-07	2.52e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—breast cancer	3.5e-07	2.37e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—breast cancer	3.47e-07	2.35e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CA—breast cancer	2.8e-07	1.9e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—breast cancer	2.29e-07	1.55e-06	CbGpPWpGaD
